Uppsala Monitoring Centre

What Uppsala Monitoring Centre does

Uppsala Monitoring Centre (UMC) is a non-profit foundation established in Uppsala, Sweden, and operating as the World Health Organization's Collaborating Centre for International Drug Monitoring. UMC runs the WHO Programme for International Drug Monitoring (PIDM), which links more than 180 national pharmacovigilance centres and provides the technical infrastructure for global medicines and vaccine safety surveillance. The organisation's foundational asset is VigiBase, the world's largest database of post-marketing adverse event reports, containing approximately 40 million reports coded in MedDRA and WHODrug Global.

UMC's product portfolio, marketed under the "Vigiverse" umbrella, consists of VigiFlow (case management and data collection for national authorities), VigiFlow eReporting for Industry (ICH E2B-compliant submissions from marketing authorisation holders), VigiMobile (a free web app for healthcare-worker and patient adverse event reporting with offline capability), VigiLyze (signal detection and management with disproportionality analysis and proprietary algorithms such as vigiMatch deduplication and pregnancy identification), and VigiBase (data access for safety research). All products share standardised drug and event terminologies, including WHODrug Global — UMC's proprietary drug dictionary — enabling interoperability across regulatory and industry workflows.

UMC operates on a subscription and membership-based revenue model: WHODrug Global is sold on subscription tiers to the pharmaceutical industry, VigiFlow and VigiLyze are provided to WHO PIDM members (with VigiMobile bundled free), and VigiBase data access is available to member organisations and other safety researchers, sometimes for a fee. Customer segments are national regulatory authorities (primary), pharmaceutical companies (primary), and downstream users such as healthcare workers and the public. Distribution is direct and web-based, supported by a comprehensive training, documentation, and education programme.

Name

Uppsala Monitoring Centre

Legal name

Uppsala Monitoring Centre

Website

https://who-umc.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Uppsala Monitoring Centre is a Swedish non-profit foundation and WHO Collaborating Centre that operates the global pharmacovigilance programme, maintaining VigiBase (40M+ adverse event reports) and providing VigiFlow, VigiLyze, VigiMobile, and WHODrug Global software to 180+ national regulatory authorities and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Software

SIC

Services-Health Services (8000)

akta.pro primary industry

Pharmacovigilance & Drug Safety Software (HLAGAJAK)

akta.pro secondary industries

Signal Detection & Safety Analytics (Epidemiology/RWE) (HLAGALAC), Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB), Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH), Medication Safety, Pharmacovigilance & Adverse Event Reporting IT (HLACAKAK)

Keywords

• Pharmacovigilance software
• Drug safety database
• Adverse event reporting
• Signal detection systems
• Drug terminology standards

Headquarters

HQ city

Uppsala

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. WHODrug Subscription: WHODrug Global, UMC's drug dictionary, is available through subscription. Access to applications, services, training, and documentation is provided through subscription tiers.
2. Software Licensing: VigiFlow and VigiLyze are provided to WHO Programme for International Drug Monitoring members, with VigiMobile included free with VigiFlow for WHO PIDM members.
3. VigiBase Data Access: VigiBase data access is available to WHO PIDM members and other organisations working with medicines and vaccine safety. A fee may apply for data requests.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

UMC develops and operates pharmacovigilance software tools including VigiFlow case management, VigiLyze signal detection, the global VigiBase database of over 40 million adverse event reports, and the WHODrug Global drug dictionary. It serves national regulatory authorities, pharmaceutical companies, and other stakeholders in the WHO Programme for International Drug Monitoring as the WHO Collaborating Centre responsible for global drug safety surveillance.

Product overview

Uppsala Monitoring Centre (UMC) offers a comprehensive pharmacovigilance product portfolio built around its Vigiverse platform. The core system consists of VigiFlow (a case management and data collection platform) supplemented by VigiMobile (for mobile adverse event reporting), VigiLyze (for signal detection and management), and VigiBase (the global database of adverse event reports). Additional offerings include VigiFlow eReporting for Industry (for ICH-compliant industry submissions) and WHODrug Global (UMC's standardised drug terminology dictionary). The products integrate standardised terminologies including MedDRA and WHODrug Global to enable systematic data mining and global pharmacovigilance analysis across the WHO Programme for International Drug Monitoring network.

Differentiator

Problem solved

Functional benefit

Brands

• Vigiverse: UMC's product suite for pharmacovigilance solutions including VigiFlow, VigiMobile, and VigiLyze
• VigiLyze
• VigiFlow
• VigiMobile
• VigiFlow eReporting for Industry
• WHODrug
• WHODrug Global
• VigiBase
• VigiAccess

Products and services

• VigiFlow Web-based case management system for national pharmacovigilance centres to capture, store, and manage individual case safety reports (ICSRs) of adverse drug reactions. Supports ICH E2B-compliant reporting and is designed for WHO PIDM member national centres.
• VigiLyze Signal detection and management platform that enables users to explore and analyse VigiBase data to identify potential drug safety signals. Supports statistical and qualitative signal detection workflows for regulators and pharmaceutical safety teams.
• VigiBase The WHO global pharmacovigilance database containing over 40 million anonymised individual case safety reports contributed by more than 180 member countries. Provides a unique resource for global drug safety surveillance and signal detection.
• WHODrug Global Standardized international drug dictionary maintained by UMC and used across the pharmaceutical industry for coding medicinal products in regulatory submissions, clinical trials, and pharmacovigilance. Provides a controlled, hierarchically organized vocabulary of drugs with names, ATC classifications, and ingredient details.

Quantifiable outcome

• 75% of all pregnancy cases in VigiBase can be identified by the pregnancy algorithm (91% for E2B format reports), with 92% precision

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

One partnership is on record.

• World Health Organization (WHO)flagshipStrategic or Co-development PartnerUMC is a WHO collaborating centre and operates under WHO's guidance to strengthen pharmacovigilance globally. The organisation supports the WHO Programme for International Drug Monitoring, helping to build capacity, efficiency, and effectiveness in medicines and vaccine safety surveillance worldwide.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ArisGlobal: ArisGlobal's LifeSphere Safety platform offers adverse event case management, signal detection, and regulatory reporting that overlaps directly with UMC's Vigiverse suite, serving both national authorities and pharma MAHs.
• Sparta Systems (TrackWise): TrackWise is a widely deployed quality and adverse event/complaint handling platform in life sciences, competing with VigiFlow for safety case management use cases within pharma and medical device manufacturers.
• Biovia (Dassault Systèmes): Biovia offers safety and regulatory solutions used in life sciences for adverse event tracking and compliance, competing with elements of UMC's Vigiverse platform in PV and quality workflows.
• Veeva Systems (Vault Safety): Veeva Vault Safety provides cloud-native PV case management and signal management competing with VigiFlow/VigiLyze, especially among large marketing authorisation holders seeking integrated clinical-to-safety workflows.
• Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is one of the dominant commercial pharmacovigilance safety database platforms used by large pharma and regulators; directly competes with VigiFlow and VigiLyze for case management and signal detection workloads.

Broad incumbents

• ICON plc: ICON provides pharmacovigilance and drug safety services spanning case processing, signal management, and aggregate reporting — overlapping UMC's signal analytics and PV service capabilities for pharma sponsors.
• Parexel International: Parexel is a CRO offering comprehensive pharmacovigilance services and safety reporting outsourcing, comparable to UMC's safety offerings but delivered through a broader clinical development services suite.
• IQVIA: IQVIA offers outsourced pharmacovigilance services, safety databases, and analytics across clinical research; broadly overlaps UMC's safety and signal management functions but as part of a much larger CRO/technology portfolio.

Emerging players

• CubeWerx: CubeWerx and similar emerging vendors provide ICSR / E2B integration and signal tooling; they overlap UMC's VigiFlow eReporting for Industry module and signal analytics use cases for smaller MAHs.

Others

• World Health Organization: UMC's primary strategic partner and indirect stakeholder; WHO sets the policy framework for the PIDM and provides UMC its mandate, institutional legitimacy, and access to member state regulatory authorities globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/UMCGlobalSafety
• YouTubeyoutube.com/c/UppsalaMonitoringCentre
• Facebookfacebook.com/UppsalaMonitoringCentre
• LinkedInlinkedin.com/company/uppsala-monitoring-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uppsala Monitoring Centre